Samsung BioLogics was assigned ‘grand ballroom’ for 2nd consecutive year at JP Morgan Conference
Samsung BioLogics was assigned ‘grand ballroom’ for 2nd consecutive year at JP Morgan Conference
  • Jung So-yeon
  • 승인 2020.01.16 11:21
  • 댓글 0
이 기사를 공유합니다

Samsung BioLogics took part in the "JP Morgan Healthcare Conference," the world’s largest global investment event held in San Francisco, the U.S. from Jan. 13.

Samsung BioLogics became the first Korean company to be assigned a main track in 2017 and the first Korean company to be assigned a "grand ballroom" since last year, drawing global investors’ attention.

The grand ballroom is a huge 800-seat presentation place that is reserved only for major global pharmaceutical companies such as Pfizer, Roche and Johnson & Johnson.

This year, Samsung BioLogics also made the announcement after being assigned the "grand ballroom" for the second straight year, earning its solid position in the global market and a high profile among major investors.

Samsung BioLogics presented its achievements, 2020 goals and mid- and long-term visions under the theme of "Innovation and Growth of Samsung in Biologics Industry" through the announcement on Jan. 15. The announcement was led by CEO Kim Tae-han and Vice President John Rim.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.
ND소프트